Emory University’s Achillion Pharmaceuticals ACHN Stock Holding History

Emory University’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-518,223	Closed	-$1.49M	–	51
2017 Q4	$1.49M	Buy	518,223 +180,360	+53%	+$655K	1.28%	42
2017 Q3	$1.52M	Sell	337,863 -34,464	-9%	-$153K	1.2%	51
2017 Q2	$1.71M	Sell	372,327 -114,111	-23%	-$459K	1.51%	14
2017 Q1	$2.05M	Buy	486,438 +32,336	+7%	+$134K	1.93%	15
2016 Q4	$1.88M	Buy	+454,102	New	+$2.41M	1.85%	15

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Emory University's ACHN Position: Q1 2018 in Review

Emory University sold out of Achillion Pharmaceuticals (ACHN) in Q1 2018, closing a stake of 518,223 shares — an estimated $1.49M sold.

Emory University first reported a position in ACHN in Q4 2016 and held it in 5 quarters. The position peaked at $2.05M in Q1 2017. 127 funds tracked by Wall St. Rank hold ACHN as of Q1 2018.

Emory University reported no remaining Achillion Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Emory University sold 518,223 Achillion Pharmaceuticals shares in Q1 2018, an estimated $1.49M.
Emory University first reported a position in Achillion Pharmaceuticals in Q4 2016 and held it in 5 quarters.
Emory University's Achillion Pharmaceuticals position peaked at $2.05M in Q1 2017.
127 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2018.

Based on Emory University's 13F filing for Q1 2018, filed 14 May 2018.